{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T05:01:39Z","timestamp":1711170099095},"reference-count":26,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["YAKUGAKU ZASSHI"],"published-print":{"date-parts":[[2023,5,1]]},"DOI":"10.1248\/yakushi.22-00192","type":"journal-article","created":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T22:15:47Z","timestamp":1682892947000},"page":"471-476","source":"Crossref","is-referenced-by-count":1,"title":["Physicochemical Properties of Branded and Generic Infusion Fluid Preparations: Results of a Comparative Experimental Study on Type 2 Hypotonic Infusion Fluid"],"prefix":"10.1248","volume":"143","author":[{"given":"Sawako","family":"Takei","sequence":"first","affiliation":[{"name":"Center for Experimental Pharmacy Practice, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soh","family":"Katsuyama","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Nihon Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Hori","sequence":"additional","affiliation":[{"name":"Center for Experimental Pharmacy Practice, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Shiraga H., Igarashi T., \u201cWakaru Yueki, Lectures in Pediatrics,\u201d Vol. IV, No. 3, Chap. 1\u201310, ed. by Shiraga H., Sogo Igaku Sha, Tokyo, 2014, pp. 553\u2013557."},{"key":"2","unstructured":"2) National Institute for Health and Care Excellence. \u201cIntravenous fluid therapy in pediatric patients and young people in hospital (NICE guideline).\u201d: \u3008https:\/\/www.nice.org.uk\/guidance\/ng29\u3009, cited 1 November 2022."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Guarino A., Ashkenazi S., Gendrel D., Vecchio A. L., Shamir R., Szajewska H., <i>J. Pediatr. Gastroenterol. Nutr.<\/i>, <b>59<\/b>, 132\u2013152 (2014).","DOI":"10.1097\/MPG.0000000000000375"},{"key":"4","unstructured":"4) Suzuki Y., \u201cInfusion Management 2021\u201322,\u201d ed. by Suzuki T., Sogo Igaku Sha, Tokyo, 2021, pp. 461\u2013467."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Feld L. G., Neuspiel D. R., Foster B. A., Leu M. G., Garber M. D., Austin K., Basu R. K., Conway E. E. Jr., Fehr J. J., Hawkins C., Kaplan R. L., Rowe E. V., Waseem M., Moritz M. L., <i>Pediatrics<\/i>, <b>142<\/b>, e20183083 (2018).","DOI":"10.1542\/peds.2018-3083"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kumar M., Mitra K., Jain R., <i>Paediatr. Int. Child Health<\/i>, <b>40<\/b>, 44\u201349 (2020).","DOI":"10.1080\/20469047.2019.1619059"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bagri N. K., Saurabh V. K., Basu S., Kumar A., <i>Indian J. Pediatr.<\/i>, <b>86<\/b>, 1011\u20131016 (2019).","DOI":"10.1007\/s12098-019-03011-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lehtiranta S., Honkila M., Kallio M., Paalanne N., Peltoniemi O., Pokka T., Renko M., Tapiainen T., <i>JAMA Pediatr.<\/i>, <b>175<\/b>, 28\u201335 (2021).","DOI":"10.1001\/jamapediatrics.2020.3383"},{"key":"9","unstructured":"9) Ministry of Health, Labour and Welfare. \u201cPercentage of generic drugs used by each insurer (For medical treatment March 2022).\u201d: \u3008https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000190726.html\u3009, cited 7 January 2023."},{"key":"10","unstructured":"10) Ministry of Health, Labour and Welfare. \u201cPharmaceutical safety and environmental health bureau June 8, 2017, Yakuseianhatsu 0608 No. 1, Notes on the description procedure of package inserts for medical drugs.\u201d: \u3008https:\/\/www.mhlw.go.jp\/web\/t_doc?dataId=00tc2704&amp;dataType=1&amp;pageNo=1\u3009, cited 1 November 2022."},{"key":"11","unstructured":"11) Generic Drug Quality Information Study Group. \u201cList of data sheets for the latest quality information on medical drugs (Blue Book).\u201d: \u3008https:\/\/www.nihs.go.jp\/drug\/ecqaged\/bluebook\/list.html\u3009, cited 1 November 2022."},{"key":"12","unstructured":"12) Costanzo L. S., \u201cPhysiology,\u201d 6th ed., Chap. 7, ed. by Jennifer E., Daniel F., Elsevier, Philadelphia, 2018, pp. 328\u2013330."},{"key":"13","unstructured":"13) Yumoto T., Aoki M., \u201cThushayaku, Yueki no Haigohhenka,\u201d 2nd ed., Chap. 3, ed. by Akase T., Nakamura H., Yodosha, Tokyo, 2017, pp. 44\u201349."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Gazitua R., Wilson K., Bistrian B. R., Blackburn G. L., <i>Arch. Surg.<\/i>, <b>114<\/b>, 897\u2013900 (1979).","DOI":"10.1001\/archsurg.1979.01370320029005"},{"key":"15","unstructured":"15) Takei S., Ohara H., Kageyama M., Tobari H., Besshoh S., Hamada M., Inoue M., Samizo K., Kuramoto K., <i>J. Drug. Interact. Res.<\/i>, <b>39<\/b>, 135\u2013144 (2016)."},{"key":"16","unstructured":"16) Takei S., Ohara H., Kageyama M., Tobari H., Besshoh S., Hamada M., Masuda T., Ohyama K., Katsuyama S., Inoue M., Kuramoto K., <i>J. Jpn. Soc. Clin. Inf. Parente.<\/i>, <b>6<\/b>, 25\u201335 (2017)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Takei S., Katsuyama S., Hori Y., <i>Drug Discov. Ther.<\/i>, <b>15<\/b>, 241\u2013247 (2021).","DOI":"10.5582\/ddt.2021.01083"},{"key":"18","unstructured":"18) Sugiura S., Tanimura M., Taniguchi T., Miyake T., Nagata H., <i>Pharmaceuticals (Ott.)<\/i>, <b>40<\/b>, 1096\u20131102 (1998)."},{"key":"19","unstructured":"19) The Ministry of Health, Labour and Welfare. \u201cThe Japanese pharmacopoeia, 18th edition (JP XV III.), General Test method, pH determination.\u201d: \u3008https:\/\/www.mhlw.go.jp\/content\/11120000\/000943877.pdf\u3009, cited 1 November 2022."},{"key":"20","unstructured":"20) Costanzo L. S., \u201cPhysiology,\u201d 6th ed., Chap. 7, ed. by Jennifer E., Daniel F., Elsevier, Philadelphia, 2018, p. 324."},{"key":"21","unstructured":"21) Kissei Pharmaceutical Co, Ltd. \u201cInterview form of DOPRAM<sup>\u00ae<\/sup> 400\u2009mg injectable, 2020.\u201d: \u3008https:\/\/med.kissei.co.jp\/dst01\/pdf\/if_dp.pdf\u3009, cited 1 November 2022."},{"key":"22","unstructured":"22) LTL pharma corporation. \u201cPerdipine<sup>\u00ae<\/sup> Injection 2\u2009mg, 10\u2009mg Combination Change Chart,\u201d 5th ed.: \u3008https:\/\/www.ltl-pharma.com\/common\/pdf\/product\/perdipine\/perdipine_ij_bct.pdf\u3009, cited 1 November 2022."},{"key":"23","unstructured":"23) Alfresa Pharma Corporation. \u201cInterview form of DROLEPTAN<sup>\u00ae<\/sup> Injection 25\u2009mg, 2021.\u201d: \u3008https:\/\/www.alfresa-pharma.co.jp\/product\/attach\/PRODUCT_ID\/544\/FILE_ID\/INTERVIEW_FORM\/544_INTERVIEW_FORM\u3009, cited 1 November 2022."},{"key":"24","unstructured":"24) Bayer Yakuhin Ltd. \u201cInterview form of Ciproxan<sup>\u00ae<\/sup> intravenous injection 200\u2009mg, 2022, 300\u2009mg.\u201d: \u3008https:\/\/pharma-navi.bayer.jp\/sites\/g\/files\/vrxlpx9646\/files\/2022-09\/CIP_ING_IVF_202209120.pdf\u3009, cited 26 September, 2022."},{"key":"25","unstructured":"25) Mitsubishi Tanabe Pharma Corporation. \u201cInterview form of Haloperidol INJECTION 5\u2009mg \u201cYOSHITOMI,\u201d 2020.\u201d: \u3008https:\/\/medical.mt-pharma.co.jp\/di\/file\/if\/f_lin_n.pdf\u3009, cited 1 November 2022."},{"key":"26","unstructured":"26) Ishii I., Suzuki T., Takahashi H., Makino H., \u201cChushayakuchozai Kansamanyuaru 2021,\u201d Elsevier Japan, Tokyo, 2020."}],"container-title":["YAKUGAKU ZASSHI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/143\/5\/143_22-00192\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T03:59:26Z","timestamp":1683345566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/143\/5\/143_22-00192\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1248\/yakushi.22-00192","relation":{},"ISSN":["0031-6903","1347-5231"],"issn-type":[{"value":"0031-6903","type":"print"},{"value":"1347-5231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"article-number":"22-00192"}}